Clinical Trials for Jasper Therapeutics

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Jasper Therapeutics

Clinical Trials (2)

NCT06736262
A Phase 2, Open-Label, Extension Study to Evaluate Long Term Safety and Clinical Activity of Briquilimab in Participants From Jasper-Sponsored Chronic Urticaria Trials
PHASE2Enrolling by invitation
90 participants
Started: Nov 26, 2024 · Completed: Dec 1, 2026
1 condition1 sponsor19 locations
NCT06162728
Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients with Chronic Spontaneous Urticaria (CSU)
PHASE1/PHASE2Recruiting
80 participants
Started: Nov 29, 2023 · Completed: Apr 1, 2026
1 condition1 sponsor32 locations